These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1719718)
21. Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat. Dunkley ML; Rajyaguru S; McCue A; Cripps AW; Kyd JM FEMS Immunol Med Microbiol; 2003 Oct; 39(1):37-44. PubMed ID: 14556994 [TBL] [Abstract][Full Text] [Related]
22. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model. Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762 [TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa. Vaccines and immunotherapy. Pennington JE Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838 [TBL] [Abstract][Full Text] [Related]
24. [Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects]. Stanislavskiĭ ES; Joó I Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):22-31. PubMed ID: 6414198 [No Abstract] [Full Text] [Related]
25. Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and pseudomonas aeruginosa sepsis. Haberstroh J; Gilleland HE; von Specht BU Eur Surg Res; 2005; 37(5):265-73. PubMed ID: 16374008 [TBL] [Abstract][Full Text] [Related]
26. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds. Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model. Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930 [TBL] [Abstract][Full Text] [Related]
29. [An O-antigen study of Pseudomonas aeruginosa from serological group O11]. Bekina KE; Ivanova NI Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):18-20. PubMed ID: 1699370 [TBL] [Abstract][Full Text] [Related]
33. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups. Gailiene G; Pavilonis A; Kareiviene V Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282 [TBL] [Abstract][Full Text] [Related]
34. Serological typing of Pseudomonas aeruginosa. Madhubala ; Shriniwas Indian J Med Res; 1979 Jun; 69():926-32. PubMed ID: 112052 [No Abstract] [Full Text] [Related]